BI Asset Management Fondsmaeglerselskab A S Has $26.55 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• BI Asset Management Fondsmaeglerselskab A S cut its UnitedHealth Group stake by 10.9% in the first quarter, selling 12,639 shares and leaving it with 103,385 shares valued at about $26.6 million.
• UnitedHealth reported better-than-expected quarterly results, posting $7.23 EPS versus $6.76 expected and revenue of $111.65 billion, while also raising its quarterly dividend to $2.32 per share.
• Wall Street remains largely positive on the stock, with a Moderate Buy consensus rating and a target price of $409.75; several firms recently lifted price targets or upgraded their views.

BI Asset Management Fondsmaeglerselskab A S decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,385 shares of the healthcare conglomerate's stock after selling 12,639 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in UnitedHealth Group were worth $26,555,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $4,376,167,000. Capital Research Global Investors grew its stake in shares of UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock valued at $4,503,419,000 after buying an additional 7,293,009 shares in the last quarter. Capital World Investors raised its position in UnitedHealth Group by 18.8% during the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock worth $7,516,107,000 after acquiring an additional 3,439,182 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its position in shares of UnitedHealth Group by 141.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate's stock valued at $1,356,432,000 after acquiring an additional 2,410,128 shares during the period. Finally, Cardano Risk Management B.V. raised its holdings in shares of UnitedHealth Group by 864.4% in the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate's stock valued at $833,099,000 after purchasing an additional 2,262,006 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $400.86 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $415.98. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The firm has a market cap of $364.04 billion, a price-to-earnings ratio of 30.28, a P/E/G ratio of 1.61 and a beta of 0.64. The stock's fifty day moving average price is $373.69 and its two-hundred day moving average price is $329.55.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same period in the prior year, the company posted $7.20 earnings per share. UnitedHealth Group's revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be given a $2.32 dividend. The ex-dividend date is Monday, June 15th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is presently 70.09%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares of the company's stock, valued at $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on UNH. Truist Financial boosted their price target on UnitedHealth Group from $395.00 to $440.00 and gave the stock a "buy" rating in a research report on Monday, June 1st. Erste Group Bank raised UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Monday, April 27th. HSBC raised shares of UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $300.00 price objective for the company in a research report on Tuesday, April 7th. Cantor Fitzgerald restated an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Finally, Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $370.00 to $397.00 and gave the company an "overweight" rating in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $409.75.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.